Get the Stockscreener App
32.04
0.00%
0.00
After Hours:
32.04
Collegium Pharmaceutical Inc stock is traded at $32.04, with a volume of 416.11K.
It is up +0.00% in the last 24 hours and down -14.15% over the past month.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$32.04
Open:
$32.16
24h Volume:
416.11K
Relative Volume:
1.09
Market Cap:
$1.01B
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
26.92
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
-5.29%
1M Performance:
-14.15%
6M Performance:
+21.83%
1Y Performance:
-15.06%
1-Day Range:
$31.26
$32.37
1-Week Range:
$31.26
$33.98
52-Week Range:
$23.23
$39.95
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical Inc
Sector
Phone
781-713-3699
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
32.04 | 1.01B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Needham | Hold → Buy |
| Jul-30-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-07-24 | Upgrade | Jefferies | Hold → Buy |
| May-10-24 | Downgrade | Needham | Buy → Hold |
| May-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-04-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-25-23 | Reiterated | Needham | Buy |
| May-02-23 | Resumed | Jefferies | Buy |
| Aug-08-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-15-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Aug-06-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Jul-14-20 | Initiated | BWS Financial | Sell |
| May-27-20 | Initiated | Guggenheim | Neutral |
| Feb-19-20 | Resumed | Jefferies | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-03-19 | Resumed | H.C. Wainwright | Buy |
| Apr-12-19 | Resumed | Janney | Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Jan-16-19 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-18 | Reiterated | Needham | Buy |
| Dec-05-17 | Reiterated | Needham | Buy |
| Sep-11-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Reiterated | Needham | Buy |
| Sep-13-16 | Initiated | Gabelli & Co | Buy |
| Jun-01-15 | Initiated | Jefferies | Buy |
| Jun-01-15 | Initiated | Needham | Buy |
| Jun-01-15 | Initiated | Piper Jaffray | Overweight |
View All
Collegium Pharmaceutical Inc Stock (COLL) Latest News
Why retail investors pile into Collegium Pharmaceutical Inc. stock2025 Market Outlook & Momentum Based Trading Signals - newser.com
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing - GlobeNewswire
10-Year Anniversary: Collegium to Ring Nasdaq Bell Oct. 14, 2025; Highlights Jornay PM ADHD growth - Stock Titan
How interest rate cuts could boost Collegium Pharmaceutical Inc. stockMarket Risk Report & Real-Time Volume Analysis - newser.com
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates - sharewise.com
Collegium Pharmaceutical Experiences Revision in Its Stock Evaluation Amidst Market Dynamics - Markets Mojo
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know - Yahoo Finance
Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory - MSN
Published on: 2025-10-10 05:16:00 - newser.com
Collegium Pharmaceutical (NASDAQ:COLL) Receives "Hold (C)" Rating from Weiss Ratings - MarketBeat
Pattern recognition hints at Collegium Pharmaceutical Inc. upsideJobs Report & Free Technical Pattern Based Buy Signals - newser.com
Strategies to average down on Collegium Pharmaceutical Inc.July 2025 Sentiment & Community Verified Trade Alerts - newser.com
Applying sector rotation models to Collegium Pharmaceutical Inc.July 2025 Highlights & Low Risk Investment Opportunities - newser.com
How Collegium Pharmaceutical Inc. (354) stock compares with tech leaders2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Oversold Conditions For Collegium Pharmaceutical (COLL) - Nasdaq
Chronic Lower Back Pain Market Projected to Grow by 2034 | Eli Lilly, Collegium Pharmaceutical, Purdue Pharma, BioDelivery Sciences, Camurus, Braeburn, Scilex Holding, Mesoblast, AnGes MG, Kolon Life - Barchart.com
Can Collegium Pharmaceutical Inc. rally from current levelsPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is Collegium Pharmaceutical Inc. (354) stock inflation resilientJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.33 Average Price Target from Brokerages - Defense World
Will Collegium Pharmaceutical Inc. bounce back from current supportWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
Historical volatility pattern of Collegium Pharmaceutical Inc. visualized2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Long term hold vs stop loss in Collegium Pharmaceutical Inc.Weekly Risk Summary & AI Powered Market Trend Analysis - newser.com
GAMMA Investing LLC Raises Stake in Collegium Pharmaceutical, Inc. $COLL - Defense World
Will Collegium Pharmaceutical Inc. (354) stock sustain dividend payoutsGap Down & AI Powered Trade Plan Recommendations - newser.com
What drives Collegium Pharmaceutical Inc 354 stock priceEarnings Per Share Trends & High Profit Market Tips - earlytimes.in
Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders? - Yahoo Finance
Collegium Pharmaceutical Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Free Exceptional Risk Adjusted Gains - earlytimes.in
Collegium Pharmaceutical Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Farther Finance Advisors LLC Boosts Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - Defense World
Regression analysis insights on Collegium Pharmaceutical Inc. performanceMarket Activity Recap & Daily Stock Trend Watchlist - newser.com
Collegium Pharmaceutical Inc Stock (COLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):